ICA Group Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

ICA Group Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$53.6K	Sell	51 -244	-83%	-$237K	0.03%	236
2024 Q1	$284K	Buy	295 +101	+52%	+$96K	0.06%	233
2023 Q4	$170K	Buy	+194	New	+$160K	0.04%	281
2023 Q3	–	Sell	-174	Closed	-$125K	–	988
2023 Q2	$125K	Buy	174 +105	+152%	+$81K	0.03%	292
2023 Q1	$56.7K	Buy	69 +55	+393%	+$41.5K	0.01%	461
2022 Q4	$10.1K	Buy	+14	New	+$10.3K	﹤0.01%	822

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ICA Group Wealth Management's REGN Position: Q2 2024 in Review

ICA Group Wealth Management reduced its Regeneron Pharmaceuticals (REGN) stake by 83% in Q2 2024, selling an estimated $237K and leaving 51 shares worth $53.6K. The position accounts for 0.03% of the portfolio, ranked #236.

ICA Group Wealth Management first reported a position in REGN in Q4 2022 and has held it in 6 quarters since. The position peaked at $284K in Q1 2024. 1,331 funds tracked by Wall St. Rank hold REGN as of Q2 2024.

ICA Group Wealth Management held 51 shares of Regeneron Pharmaceuticals worth $53.6K as of Q2 2024.
ICA Group Wealth Management sold 244 Regeneron Pharmaceuticals shares in Q2 2024, an estimated $237K.
Regeneron Pharmaceuticals made up 0.03% of ICA Group Wealth Management's portfolio in Q2 2024, its #236 holding.
ICA Group Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 6 quarters since.
ICA Group Wealth Management's Regeneron Pharmaceuticals position peaked at $284K in Q1 2024.
1,331 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.